M. Uytterhoeven

Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

M. Maes, E. Bosmans, M. Kubera, 2011, Medical science monitor : international medical journal of experimental and clinical research.

The effect of nutritionally induced hyperlipidaemia on in vitro bovine embryo quality.

A. Gutiérrez-Adán, A. Van Soom, P. Bols, 2010, Human reproduction.

Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease.

M. Maes, E. Bosmans, M. Kubera, 2010, Journal of affective disorders.

Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder.

M. Maes, E. Bosmans, M. Kubera, 2009, Neuro endocrinology letters.

Comparison of five commercially available ELISA kits for the determination of intrinsic factor antibodies in a vitamin B12 deficient adult population

C. Bonroy, M. Berth, W. Uyttenbroeck, 2016, International journal of laboratory hematology.

Spectrometric determination of silicon in food and biological samples: an interlaboratory trial

J. Arnaud, S. Lugowski, H. Robberecht, 2000 .

Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis / chronic fatigue syndrome.

M. Maes, E. Bosmans, M. Kubera, 2009, Neuro endocrinology letters.

Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression.

M. Maes, E. Bosmans, M. Kubera, 2011, Neuro endocrinology letters.

Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness.

M. Maes, E. Bosmans, M. Kubera, 2009, Neuro endocrinology letters.

Determination of a confirmation interval for %CDT TIA analysis.

E. Bosmans, M. Berth, M. Uytterhoeven, 2008, Clinica chimica acta; international journal of clinical chemistry.